Skip to search formSkip to main contentSkip to account menu

1 ML secukinumab 150 MG/ML Auto-Injector

Known as: SECUKINUMAB 150MG/ML INJ,PEN 1ML [VA Product], SECUKINUMAB 150MG/ML INJ 1 ML PEN, secukinumab 150 MG per 1 ML Auto-Injector 
National Institutes of Health

Related topics

Related topics

4 relations

Narrower (1)

1 ML secukinumab 150 MG/ML Auto-Injector [Cosentyx]
Auto-Injectorsecukinumab

Broader (1)

Immunosuppressive Agents

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
AB0685 Secukinumab provides sustained improvements in work productivity and health related quality of life in patients with ankylosing spondylitis: long-term results from measure 1 and measure 2
Background Patients (pts) with ankylosing spondylitis (AS) experience significant restrictions in work productivity and health… 
2016
2016
Secukinumab bremst die Röntgenprogression bei AS
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)